A Specialty Pharmaceutical company developing innovative products that improve lives.
Avondale Pharmaceuticals is a Specialty Pharmaceutical company that develops and markets a growing portfolio of innovative, branded & generic prescription pharmaceutical products.
Avondale focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available therapeutics and late-stage development products to fulfill unmet medical needs.
Our mission is to deliver quality products at affordable prices – bringing value to our customer base while providing savings and choice to patients nationwide. We are committed to developing, manufacturing, and distributing products that meet the highest quality standards through compliance with all applicable regulatory requirements.
This goal is achieved through management’s commitment to:
- Driving a culture of quality through leadership and personal accountability
- Empowering employees to share ideas for continuous improvement
- Emphasizing each employee’s role in ensuring the success of the quality system
Partnership Opportunities
Avondale Pharmaceuticals is a rapidly growing pharmaceutical company with a seasoned leadership team. We are a fast-paced, performance-based company accountable to our patients and customers to deliver meaningful and life-improving solutions.
Acquisition
We seek opportunities to acquire companies and assets that complement our portfolio of products and further our mission.
Development
We explore alternatives to improve quality, access to medications and consumer choices.
Joint Venture
We aim to collaborate with like-minded companies to deliver meaningful therapies to the market.
Latest Developments
Get the latest pharmaceutical, industry, and company news here
Avondale Pharmaceuticals, LLC signs development agreement with Oxford Pharmaceuticals, LLC
BIRMINGHAM, Ala., July 17, 2018 /PRNewswire/ — Avondale Pharmaceuticals, LLC, announced today an exclusive, product development partnership with Oxford Pharmaceuticals, a pharmaceutical manufacturer and distributor based in Birmingham, AL. John Schultz, President of Oxford said “Oxford is extremely pleased to continue its relationship with Avondale through this partnership to advance the capabilities and experience of […]